Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTS
2026
DELISTED
Triple-S Management Corporation
GTS
| $2.72M | 0.01% |
114,991
+32,794
| +40% | +$735K |
|
|
OPB
2027
DELISTED
Opus Bank Common Stock
OPB
| $2.72M | 0.01% |
80,000
-51,172
| -39% | -$1.69M |
|
2028
Rush Enterprises Class A
RUSHA
$9.6B
| $2.72M | 0.01% |
+335,201
| New | +$2.7M |
|
|
AHGP
2029
DELISTED
Alliance Holdings GP
AHGP
| $2.72M | 0.01% |
185,850
+49,196
| +36% | +$746K |
|
2030
Espey Mfg & Electronics Corp
ESP
$192M
| $2.71M | 0.01% |
110,300
+2,000
| +2% | +$50.2K |
|
|
CTT
2031
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $2.71M | 0.01% |
250,100
+88,000
| +54% | +$943K |
|
2032
Suburban Propane Partners
SPH
$1.18B
| $2.71M | 0.01% |
90,567
-337,400
| -79% | -$8.88M |
|
2033
German American Bancorp
GABC
$1.93B
| $2.69M | 0.01% |
125,250
+13,800
| +12% | +$291K |
|
|
XCO
2034
DELISTED
Exco Resources
XCO
| $2.68M | 0.01% |
180,600
+49,053
| +37% | +$813K |
|
2035
Willdan Group
WLDN
$1.32B
| $2.67M | 0.01% |
277,200
+5,600
| +2% | +$46.6K |
|
2036
Foster
FSTR
$408M
| $2.66M | 0.01% |
146,400
+1,300
| +0.9% | +$17.3K |
|
|
NAME
2037
DELISTED
Rightside Group, Ltd.
NAME
| $2.65M | 0.01% |
329,505
-23,439
| -7% | -$198K |
|
2038
Global Indemnity Group
GBLI
$396M
| $2.65M | 0.01% |
85,157
-1,007
| -1% | -$29.4K |
|
2039
Choice Hotels
CHH
$4.7B
| $2.64M | 0.01% |
48,900
+8,000
| +20% | +$384K |
|
|
RPTP
2040
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $2.64M | 0.01% |
572,946
+40,066
| +8% | +$161K |
|
|
AM
2041
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $2.63M | 0.01% |
119,100
-21,200
| -15% | -$451K |
|
2042
Liberty Global Class C
LBTYK
$3.49B
| $2.63M | 0.01% |
80,657
-190,656
| -70% | -$5.8M |
|
|
CIVI
2043
DELISTED
Civitas Resources
CIVI
| $2.63M | 0.01% |
14,795
+4,152
| +39% | +$1.1M |
|
2044
Financial Institutions
FISI
$823M
| $2.62M | 0.01% |
90,200
+13,500
| +18% | +$368K |
|
2045
Archrock
AROC
$6.08B
| $2.62M | 0.01% |
+327,190
| New | +$1.82M |
|
|
AMTG
2046
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $2.62M | 0.01% |
+194,900
| New | +$2.28M |
|
2047
Tetra Tech
TTEK
$9.35B
| $2.62M | 0.01% |
438,500
-190,100
| -30% | -$1.01M |
|
2048
Gray Television
GTN
$538M
| $2.61M | 0.01% |
+222,850
| New | +$2.74M |
|
2049
Alpha Pro Tech
APT
$55.4M
| $2.61M | 0.01% |
1,434,298
-18,700
| -1% | -$31.5K |
|
2050
Transact Technologies
TACT
$53.2M
| $2.6M | ﹤0.01% |
319,871
+1,871
| +0.6% | +$14.6K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.